ANTX   $1.29  21.70% Market Closed After Close 1.29 0.0

AN2 Therapeutics Inc
Total Cash 104.54M
totalCashPerShare 3.503
EBITDA
Total Debt 0.00
quickRatio 10.353
currentRatio 10.609
Total Revenue
debtToEquity
Revenue/Share
ROA -0.42893
ROE -0.6948
grossProfits
freeCashflow -36.40M
operatingCashflow -60.84M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -71.71M
forwardPE -0.9482759
floatShares 11.39M
sharesOutstanding 29.84M
sharesShort 139.12K
sharesShortPriorMonth 249.63K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.62%
Short Ratio help_outline 0.84%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 3.297
Price To Book help_outline 0.33
earningsQuarterlyGrowth
netIncomeToCommon -64.66M
trailingEps -2.18%
forwardEps -1.16%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 57
lastUpdated Nov. 7, 2024, 12:59 p.m.